BioMarin Pharma (BMRN) Plans Presentations at Study of Inborn Errors of Metabolism 2015 Annual Meeting
Tweet Send to a Friend
BioMarin Pharma (NASDAQ: BMRN) announced today that the company will present data in two oral and 19 poster presentations at ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
